Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection

Li, Roger; Hensley, Patrick J.; Gupta, Shilpa; Al-Ahmadie, Hikmat; Babjuk, Marko; Black, Peter C.; Brausi, Maurizio; Bree, Kelly K.; Fernández, Mario I.; Guo, Charles C.; Horowitz, Amir; Lamm, Donald L.; Lerner, Seth P.; Lotan, Yair; Mariappan, Paramananthan; McConkey, David; Mertens, Laura S.; Mir, Carmen; Ross, Jeffrey S.; O’Donnell, Michael; Palou, Joan; Pohar, Kamal; Steinberg, Gary; Soloway, Mark; Spiess, Philippe E.; Svatek, Robert S.; Tan, Wei Shen; Taoka, Rikiya; Buckley, Roger; Kamat, Ashish M.

doi:10.1016/j.eururo.2024.08.001

European Urology

2024

DOI: 10.1016/j.eururo.2024.08.001

|View full text |Cite

Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection

Roger Li,

Patrick J. Hensley,

Shilpa Gupta

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article4

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin–Unresponsive Non–Muscle Invasive Bladder Cancer

Taylor,

Kamat,

Annapureddy

et al. 2024

European Urology Oncology

View full text Add to dashboard Cite

Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin–Unresponsive Non–Muscle Invasive Bladder Cancer

Taylor,

Kamat,

Annapureddy

et al. 2024

European Urology Oncology

View full text Add to dashboard Cite

Navigating the Challenges of BCG-Unresponsive Non–muscle-invasive Bladder Cancer: Insights and Future Directions

Shariat

2024

European Urology

View full text Add to dashboard Cite

CD105-microvessel density analysis and its clinical value in urothelial carcinoma of bladder patients

Siddhartha,

Singhai,

Goel

et al. 2024

Biomarkers

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection

Cited by 4 publications

References 48 publications

Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin–Unresponsive Non–Muscle Invasive Bladder Cancer

Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin–Unresponsive Non–Muscle Invasive Bladder Cancer

Navigating the Challenges of BCG-Unresponsive Non–muscle-invasive Bladder Cancer: Insights and Future Directions

CD105-microvessel density analysis and its clinical value in urothelial carcinoma of bladder patients

Contact Info

Product

Resources

About